Statistical Analysis by Semiparametric Additive Regression and LSTM-FCN Based Hierarchical Classification for Computer Vision Quantification of Parkinsonian Bradykinesia
Authors:
Youngseo Cho,
In Hee Kwak,
Dohyeon Kim,
**hee Na,
Hanjoo Sung,
Jeongjae Lee,
Young Eun Kim,
Hyeo-il Ma
Abstract:
Bradykinesia, characterized by involuntary slowing or decrement of movement, is a fundamental symptom of Parkinson's Disease (PD) and is vital for its clinical diagnosis. Despite various methodologies explored to quantify bradykinesia, computer vision-based approaches have shown promising results. However, these methods often fall short in adequately addressing key bradykinesia characteristics in…
▽ More
Bradykinesia, characterized by involuntary slowing or decrement of movement, is a fundamental symptom of Parkinson's Disease (PD) and is vital for its clinical diagnosis. Despite various methodologies explored to quantify bradykinesia, computer vision-based approaches have shown promising results. However, these methods often fall short in adequately addressing key bradykinesia characteristics in repetitive limb movements: "occasional arrest" and "decrement in amplitude."
This research advances vision-based quantification of bradykinesia by introducing nuanced numerical analysis to capture decrement in amplitudes and employing a simple deep learning technique, LSTM-FCN, for precise classification of occasional arrests. Our approach structures the classification process hierarchically, tailoring it to the unique dynamics of bradykinesia in PD.
Statistical analysis of the extracted features, including those representing arrest and fatigue, has demonstrated their statistical significance in most cases. This finding underscores the importance of considering "occasional arrest" and "decrement in amplitude" in bradykinesia quantification of limb movement. Our enhanced diagnostic tool has been rigorously tested on an extensive dataset comprising 1396 motion videos from 310 PD patients, achieving an accuracy of 80.3%. The results confirm the robustness and reliability of our method.
△ Less
Submitted 31 March, 2024;
originally announced April 2024.
Materials Discovery with Extreme Properties via Reinforcement Learning-Guided Combinatorial Chemistry
Authors:
Hyunseung Kim,
Haeyeon Choi,
Dongju Kang,
Won Bo Lee,
Jonggeol Na
Abstract:
The goal of most materials discovery is to discover materials that are superior to those currently known. Fundamentally, this is close to extrapolation, which is a weak point for most machine learning models that learn the probability distribution of data. Herein, we develop reinforcement learning-guided combinatorial chemistry, which is a rule-based molecular designer driven by trained policy for…
▽ More
The goal of most materials discovery is to discover materials that are superior to those currently known. Fundamentally, this is close to extrapolation, which is a weak point for most machine learning models that learn the probability distribution of data. Herein, we develop reinforcement learning-guided combinatorial chemistry, which is a rule-based molecular designer driven by trained policy for selecting subsequent molecular fragments to get a target molecule. Since our model has the potential to generate all possible molecular structures that can be obtained from combinations of molecular fragments, unknown molecules with superior properties can be discovered. We theoretically and empirically demonstrate that our model is more suitable for discovering better compounds than probability distribution-learning models. In an experiment aimed at discovering molecules that hit seven extreme target properties, our model discovered 1,315 of all target-hitting molecules and 7,629 of five target-hitting molecules out of 100,000 trials, whereas the probability distribution-learning models failed. Moreover, it has been confirmed that every molecule generated under the binding rules of molecular fragments is 100% chemically valid. To illustrate the performance in actual problems, we also demonstrate that our models work well on two practical applications: discovering protein docking molecules and HIV inhibitors.
△ Less
Submitted 7 May, 2024; v1 submitted 21 March, 2023;
originally announced March 2023.
